151 related articles for article (PubMed ID: 33833527)
1. LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway.
Li J; Xu X; Zhang D; Lv H; Lei X
Onco Targets Ther; 2021; 14():2293-2300. PubMed ID: 33833527
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis.
Wang W; Zhang Z; Li Y; Gu A; Wang Y; Cai Y; Yu Y; Deng X
Bioengineered; 2022 Mar; 13(3):5421-5433. PubMed ID: 35176945
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
Li H; Jiang J
J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DS Cell Adhesion Molecule Antisense RNA 1 Facilitates Oral Squamous Cell Carcinoma Progression through The microRNA-138-5p/ Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Axis.
Zhang Y; Wang X; Wang P; Zhang X; Han SH; Huo F
Cell J; 2022 May; 24(5):222-229. PubMed ID: 35717565
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma.
Wang F; Ji X; Wang J; Ma X; Yang Y; Zuo J; Cui J
Onco Targets Ther; 2020; 13():243-252. PubMed ID: 32021271
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients.
Wang X; Guo Y; Wang C; Wang Q; Yan G
Onco Targets Ther; 2021; 14():2699-2710. PubMed ID: 33888994
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LHFPL3-AS1 contributes to tumorigenesis of melanoma stem cells via the miR-181a-5p/BCL2 pathway.
Zhang S; Wan H; Zhang X
Cell Death Dis; 2020 Nov; 11(11):950. PubMed ID: 33149126
[TBL] [Abstract][Full Text] [Related]
9. lncRNA MCM3AP-AS1 promotes the development of oral squamous cell carcinoma by inhibiting miR-363-5p.
Hou C; Wang X; Du B
Exp Ther Med; 2020 Aug; 20(2):978-984. PubMed ID: 32742341
[TBL] [Abstract][Full Text] [Related]
10. Exosomal-mediated transfer of APCDD1L-AS1 induces 5-fluorouracil resistance in oral squamous cell carcinoma via miR-1224-5p/nuclear receptor binding SET domain protein 2 (NSD2) axis.
Li S; Shi Z; Fu S; Li Q; Li B; Sang L; Wu D
Bioengineered; 2021 Dec; 12(1):7188-7204. PubMed ID: 34546854
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
[TBL] [Abstract][Full Text] [Related]
12. lncRNA TMEM161B-AS1 screened the onset of oral squamous cell carcinoma in HPV-infected patients, predicted poor prognosis, and regulated cell progression via modulating the miR-651-5p/BDNF axis.
Wang M; Han Z; Wang X; Cheng Y; Cao Z; Zhang Y; Zhang Y
Odontology; 2024 Feb; ():. PubMed ID: 38376795
[TBL] [Abstract][Full Text] [Related]
13. COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma.
Deng J; Wu M
Am J Transl Res; 2023; 15(3):2191-2206. PubMed ID: 37056821
[TBL] [Abstract][Full Text] [Related]
14. Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p.
Wang Q; Han J; Xu P; Jian X; Huang X; Liu D
Cancer Manag Res; 2021; 13():1831-1841. PubMed ID: 33654431
[TBL] [Abstract][Full Text] [Related]
15. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis.
Xiao Z; Li J; Jin Q; Liu D
Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
[TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DGUOK-AS1 Promotes Cell Progression in Lung Squamous Cell Carcinoma by Regulation of miR-653-5p/SLC6A15 Axis.
Teng Y; Li S; Wei L; Zhang C; Li L; Wang S; Zhang J; Huang J; Zhang H; Wu N; Liu J
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38407689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
